Members of the Judiciary
Speaker

Honorable Leonard P. Stark

United States Judge
U.S. Court of Appeals for the Federal Circuit
(Former Chief Judge, United States District Court, District of Delaware)

Speaker

Honorable Julien Zavier Neals

District Judge
United States District Court, District of New Jersey

Speaker

Honorable Stanley R. Chesler

District Judge
United States District Court, District of New Jersey

Speaker

Honorable Maryellen Noreika

District Judge
United States District Court, District of Delaware

Speaker

Honorable Mitchell Goldberg

District Judge
United States District Court, Eastern District of Pennsylvania
(Visiting Judge, District of Delaware)

Speaker

Honorable Joshua Wolson

District Judge
United States District Court

Eastern District of Pennsylvania
(Visiting Judge, District of Delaware)

Speaker

Honorable Douglas E. Arpert

Magistrate Judge
United States District Court, District of New Jersey

Speaker

Honorable Christopher J. Burke

Magistrate Judge
District of Delaware

Government Representatives from U.S. Patent and Trademark Office
Speaker

Honorable Jacqueline Bonilla

Deputy Chief Administrative Patent Judge, Patent Trial & Appeal Board
U.S. Patent and Trademark Office

Speaker

Honorable Susan Mitchell

Lead Judge, Patent Trial & Appeal Board
U.S. Patent and Trademark Office

Speaker

Honorable Grace Obermann

Administrative Patent Judge, Patent Trial & Appeal Board
U.S. Patent and Trademark Office

2023 Co-Chairs
Speaker

Honorable Kathleen M. O’Malley (Ret.)

Of Counsel
Irell & Manella LLP
(Former United States Circuit Judge U.S. Court of Appeals for the Federal Circuit)

Speaker

Neema Kumar

Vice President, IP, North America
Sandoz

Speaker

Serena Farquharson Torres

Executive Director, Assistant General Counsel
Bristol Myers Squibb

Join the conference that the “who’s who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice.

Since 2006, when we launched our inaugural conference, pharmaceutical patent practitioners from throughout the country and in some instances across the globe have attended this conference to confer with each other and assess the implications and imprimaturs of court cases, legislation, and industry behaviors which affect the patent endgame and the pursuit of related profits. They also come to hear from Judges — both from the federal judiciary, and U.S. P.T.O.’s PTAB —, the FTC, and the FDA.

Leaders from both brand and generic drug companies recognize that this event is the single forum which serves both sides of the industry and is second to none in offering both legal and economic “take aways” for every sphere of this costly, complex and evolving litigation. This is the only event on market which not only addresses the hot topics, but also puts them within the context of pre-suit considerations, case filings, final adjudication and every step in between. This unique dynamic exemplifies not only the importance of the content and legal theory presented, but the contending business acuities as well.

We invite you to join us at this flagship event to get caught up on legal developments and learn how your peers (and opponents) are navigating the ever-changing landscape – but don’t just take our word for it, hear from Michael Sitzman (DLA Piper), Huong T. Nguyen (Fosun Pharma USA Inc.), Evan Diamond (King & Spalding LLP), and Ryan M. Daniel (Fresenius Kabi USA, LLC) about why they value this event.

A REVIEW OF ACI’s PARAGRAPH IV DISPUTES CONFERENCES

3,700+

Attendees

560+

Speakers

110+

Sponsors

DISTINGUISHED FACULTY

The best that the bar, the bench, and the industry have to offer

MASTER LEVEL STRATEGIES

For litigators and in-house counsel

UNPARALLELED CONNECTIONS

With the “Who’s Who” of Hatch-Waxman litigators

Worry Free
Concerned About Traveling?
Check out our WORRY-FREE GUARANTEE

Register at the preferred early rate with our worry free cancellation guarantee.

Learn More